Fandrick Keith, Feng Xianqi, Janowsky Aaron, Johnson Robert, Cashman John R
Human BioMolecular Research Institute, 5310 Eastgate Mall, 92121, San Diego, CA, USA.
Bioorg Med Chem Lett. 2003 Jul 7;13(13):2151-4. doi: 10.1016/s0960-894x(03)00386-x.
A series of aryltropane-based bivalent ligands was prepared and investigated for binding potency and for their ability to inhibit reuptake of human dopamine, serotonin and norepinephrine transporters. The bivalent ligand 4, comprised of linking an aryltropane by an octamethylene spacer showed high efficacy for the human dopamine transporter and had a discrimination ratio of 130.
制备了一系列基于芳基托烷的二价配体,并研究了它们的结合效力以及抑制人多巴胺、5-羟色胺和去甲肾上腺素转运体再摄取的能力。由八亚甲基间隔基连接芳基托烷组成的二价配体4对人多巴胺转运体显示出高效力,区分率为130。